Publikation
Survival of recurrent/metastatic head and neck squamous cell cancer (r/mHNSCC) patients (pts) treated in 1st or 2nd line with an anti-EGFR-antibody (EAB)
Präsentation/Vortrag - 10.10.2015
Siano Marco
Bereiche
Kontakt
Zitation
Siano M (2015). Survival of recurrent/metastatic head and neck squamous cell cancer (r/mHNSCC) patients (pts) treated in 1st or 2nd line with an anti-EGFR-antibody (EAB). Präsentiert bei: DGHO 2015, Basel
Art
Präsentation/Vortrag (Deutsch)
Name der Veranstaltung
DGHO 2015 (Basel)
Veröffentlichungsdatum
10.10.2015
Kurzbeschreibung/Zielsetzung
Siano M, Desax MC, Früh M, Jörger M. Survival of recurrent/metastatic head and neck squamous cell cancer (r/mHNSCC) patients (pts) treated in 1st or 2nd line with an anti-EGFR-antibody (EAB). Oncol Res Treat 2015;38(suppl 5):186. abstract V614.